1/20/2022 9:03:19 AM
Sorrento Therapeutics Announces Covishield Potently Neutralizes Omicron And Omicron Variants Of Sars-Cov-2
4/5/2021 9:07:36 AM
Sorrento Therapeutics To Acquire ACEA Therapeutics
1/26/2021 7:42:56 PM
Sorrento Reports Positive Preliminary Results Of Phase 1b Study Of COVI-MSC For Treatment Of ICU COVID-19 Patients
12/22/2015 8:34:03 AM
FBR Capital Markets Initiates Sorrento Therapeutics, Inc. (SRNE) At Outperform With $22 Price Target